Clinical Trial Update: Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) [Phase 3]

View source ↗

Summary

A Phase 3 long-term open-label study of pitolisant (BF2.649) for narcolepsy with cataplexy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataplexy
• Narcolepsy

Drugs mentioned

• Pitolisant (pitolisant)

Snippet

Sponsor: Bioprojet | Conditions: Narcolepsy, Cataplexy | Phase 3 | Status: COMPLETED